Literature DB >> 16157387

Generation of lentiviral transgenic rats expressing glutamate receptor interacting protein 1 (GRIP1) in brain, spinal cord and testis.

Terunaga Nakagawa1, Monica I Feliu-Mojer, Phebe Wulf, Carlos Lois, Morgan Sheng, Casper C Hoogenraad.   

Abstract

In neuroscience, rats have several advantages over mice as a model organism. For instance, behavioral experiments are more advanced and the larger size of the brain is better suited for surgical manipulation and biochemistry. Furthermore, the vascular physiology of rats is considered closer to human, providing clinical relevance. Because transgenesis rates achieved by conventional pronuclear injection are extremely low (0.2-3.5%), the availability of transgenic rats in neuroscience is limited. Lentivirus infection is an efficient way to integrate exogenous genes into the genome of a one-cell embryo to generate transgenic animals. We report here the generation of synapsin I promoter driven GRIP1-transgenic rats using lentiviral transgenesis. GRIP1 was chosen as a transgene because it interacts with AMPA receptors and is involved in glutamate receptor signaling. From a single infection experiment, 45% of the offspring carried the transgene and 40% achieved germ-line transmission. The expression of GRIP1 was observed at low levels in brain, spinal cord and testis. Interestingly, one transgenic copy lacked a 147 bp fragment in the GRIP1 coding region most likely caused by alternative splicing of genomic lentiviral RNA. Co-immunoprecipitation from rat brains showed that transgenic GRIP1 is in complex with the endogenous GluR2 subunit of AMPA receptors. These results indicate that functional transgenic GRIP1 protein is expressed in rat brain using lentiviral vectors containing a human synapsin I promoter. Tissue specific lentiviral transgenic rats will be a powerful tool for various applications in modern neuroscience.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157387     DOI: 10.1016/j.jneumeth.2005.08.001

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  6 in total

1.  Oviduct-specific expression of two therapeutic proteins in transgenic hens.

Authors:  S G Lillico; A Sherman; M J McGrew; C D Robertson; J Smith; C Haslam; P Barnard; P A Radcliffe; K A Mitrophanous; E A Elliot; H M Sang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-26       Impact factor: 11.205

2.  Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132.

Authors:  Dieter Edbauer; Joel R Neilson; Kelly A Foster; Chi-Fong Wang; Daniel P Seeburg; Matthew N Batterton; Tomoko Tada; Bridget M Dolan; Phillip A Sharp; Morgan Sheng
Journal:  Neuron       Date:  2010-02-11       Impact factor: 17.173

Review 3.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22

Review 4.  New technology for an old favorite: lentiviral transgenesis and RNAi in rats.

Authors:  Christina Tenenhaus Dann
Journal:  Transgenic Res       Date:  2007-08-08       Impact factor: 2.788

5.  Evaluation of laser-assisted lentiviral transgenesis in bovine.

Authors:  Sonja Ewerling; Andreas Hofmann; Regina Klose; Myriam Weppert; Gottfried Brem; Klaus Rink; Alexander Pfeifer; Eckhard Wolf
Journal:  Transgenic Res       Date:  2006-08       Impact factor: 3.145

6.  Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing.

Authors:  Martin H Schludi; Stephanie May; Friedrich A Grässer; Kristin Rentzsch; Elisabeth Kremmer; Clemens Küpper; Thomas Klopstock; Thomas Arzberger; Dieter Edbauer
Journal:  Acta Neuropathol       Date:  2015-06-18       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.